Direct radiolabeling by [3H]quisqualic acid of group I metabotropic glutamate receptor in rat brain synaptic membranes. 2000

E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
Department of Molecular Pharmacology, Kanazawa University Faculty of Pharmaceutical Sciences, 13-1 Takara-machi, Kanazawa, 920-0934, Ishikawa, Japan.

[3H]Quisqualic acid (QA) was synthesized and used to label metabotropic glutamate receptor (mGluR) in rat brain synaptic membranes in the presence of three different ionotropic glutamate receptor agonists at respective saturating concentrations. Of several mGluR agonists tested, group I agonists were more potent in displacing [3H]QA binding than group II and group III agonists in the presence of the three ionotropic agonists. [3H]QA binding was markedly inhibited by guanine nucleotide analogues in a concentration-dependent manner at a concentration range of 10 nM to 1 mM. Scatchard analysis revealed that [3H]QA binding consisted of a single component with a K(d) of 50.9+/-5.3 nM and a B(max) of 431. 6+/-18.3 fmol/mg protein. These results suggest that [3H]QA indeed labels group I mGluR functionally coupled to GTP binding protein in rat brain synaptic membranes when determined under the experimental conditions employed.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006160 Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP,Triphosphate, Guanosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013570 Synaptic Membranes Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters. Membrane, Synaptic,Membranes, Synaptic,Synaptic Membrane
D016318 Quisqualic Acid An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. Quisqualate
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018094 Receptors, Metabotropic Glutamate Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action. Glutamate Receptors, Metabotropic,Metabotropic Glutamate Receptors,Receptors, Glutamate, Metabotropic,Metabotropic Glutamate Receptor,Glutamate Receptor, Metabotropic,Receptor, Metabotropic Glutamate
D018690 Excitatory Amino Acid Agonists Drugs that bind to and activate excitatory amino acid receptors. Amino Acids, Excitatory, Agonists,Glutamate Agonists,Agonists, Excitatory Amino Acid,Amino Acid Agonist, Excitatory,Amino Acid Agonists, Excitatory,EAA Agonist,EAA Agonists,Excitatory Amino Acid Agonist,Glutamate Agonist,Agonist, EAA,Agonist, Glutamate,Agonists, EAA,Agonists, Glutamate

Related Publications

E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
March 1998, Bioorganic & medicinal chemistry letters,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
August 2001, The Journal of pharmacology and experimental therapeutics,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
July 2003, Cell and tissue research,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
January 1997, Journal fur Hirnforschung,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
September 1992, Neuroscience letters,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
May 1990, Neuroscience letters,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
August 2016, The Journal of biological chemistry,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
January 2002, Zeitschrift fur Naturforschung. C, Journal of biosciences,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
April 1994, Molecular pharmacology,
E Hinoi, and K Ogita, and Y Takeuchi, and H Ohashi, and T Maruyama, and Y Yoneda
February 1998, Molecular pharmacology,
Copied contents to your clipboard!